Aurinia Pharmaceuticals Financials

Values in thousands	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Revenue	$77,114	$73,468	$70,008	$62,465
Gross Profit	68,642	64,964	62,893	53,891
EBITDA	27,619	36,827	28,137	30,272
EBIT	42,204	31,962	23,273	25,416
Net Income	210,794	31,551	21,513	23,344
Net Change In Cash	77,114	73,468	70,008	62,465
Free Cash Flow	45,596	44,384	44,143	1,283
Cash	80,213	73,189	53,002	66,428
Basic Shares	138,700	136,008	143,199	138,917

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$283,055	$235,133	$175,513	$134,030
Gross Profit	250,390	206,885	161,365	128,366
EBITDA	127,757	31,728	-63,047	-108,764
EBIT	118,487	12,283	-74,694	-111,470
Net Income	287,202	5,752	-78,020	-108,180
Net Change In Cash	283,055	235,133	175,513	134,030
Free Cash Flow	135,406	44,107	-34,179	-79,821
Cash	80,213	83,433	48,875	94,172
Basic Shares	138,700	146,194	143,236	141,915